New data on the genetic profile and penetrance of hereditary Val30Met transthyretin amyloidosis in Sweden

References

• Planté-Bordeneuve V. Transthyretin familial amyloid polyneuropathy: an update. J Neurol. 2018;265:976–983.
   PubMed Web of Science ®Google Scholar
• Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 1952;75(3):408–427.
   PubMed Web of Science ®Google Scholar
• Araki S, Mawatari S, Ohta M, et al. Polyneuritic amyloidosis in a Japanese family. Arch Neurol. 1968;18(6):593–602.
   PubMedGoogle Scholar
• Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl. 1976;590:1–64.
   PubMedGoogle Scholar
• Parman Y, Adams D, Obici L, et al. Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol Suppl. 2016;29:S3–S13.
   PubMed Web of Science ®Google Scholar
• Schmidt HH, Waddington-Cruz M, Botteman MF, et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve. 2018;57(5):829–837.
   PubMed Web of Science ®Google Scholar
• Olsson M, Jonasson J, Cederquist K, et al. Frequency of the transthyretin Val30Met mutation in the northern Swedish population. Amyloid. 2014;21(1):18–20.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Costa PM, Andersson C, et al. Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet. 1994;31(5):351–354.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Hellman U, Lundgren HE, et al. Impact of homozygosity for an amyloidogenic transthyretin mutation on phenotype and long term outcome. J Med Genet. 2005;42(12):953–956.
   PubMed Web of Science ®Google Scholar
• Planté-Bordeneuve V, Carayol J, Ferreira A, et al. Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families. J Med Genet. 2003;40(11):e120.
   PubMed Web of Science ®Google Scholar
• Hellman U, Alarcon F, Lundgren HE, et al. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Amyloid. 2008;15(3):181–186.
   PubMed Web of Science ®Google Scholar
• Saporta MA, Zaros C, Cruz MW, et al. Penetrance estimation of TTR familial amyloid polyneuropathy (type I) in Brazilian families. Eur J Neurol. 2009;16(3):337–341.
   PubMed Web of Science ®Google Scholar
• Alarcon F, Planté-Bordeneuve V, Olsson M, et al. Non-parametric estimation of survival in age- dependent genetic disease and application to the transthyretin-related hereditary amyloidosis. PLoS One. 2018;13(9):e0203860.
   PubMed Web of Science ®Google Scholar
• Bouaziz O, Nuel G. A change-point model for detecting heterogeneity in ordered survival responses. Stat Methods Med Res. 2018;27(12):3595–3611.
   PubMed Web of Science ®Google Scholar
• Alarcon F, Bourgain C, Gauthier-Villars M, et al. PEL: an unbiased method for estimating age-dependent genetic disease risk from pedigree data unselected for family history. Genet Epidemiol. 2009;33(5):379–385.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing; 2015. Available from: https://www.R-project.org/.
   Google Scholar
• Holmgren G, Bergstrom S, Drugge U, et al. Homozygosity for the transthyretin-Met30-gene in seven individuals with familial amyloidosis with polyneuropathy detected by restriction enzyme analysis of amplified genomic DNA sequences. Clin Genet. 1992;41(1):39–41.
   PubMed Web of Science ®Google Scholar
• Drugge U, Andersson R, Chizari F, et al. Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis. J Med Genet. 1993;30(5):388–392.
   PubMed Web of Science ®Google Scholar
• Misu K, Hattori N, Ando Y, et al. Anticipation in early- but not late-onset familial amyloid polyneuropathy (TTR met 30) in Japan. Neurology. 2000;55(3):451–452.
   PubMed Web of Science ®Google Scholar
• Lemos C, Coelho T, Alves-Ferreira M, et al. Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M. J Neurol Neurosurg Psychiatry. 2014;85(3):326–330.
   PubMed Web of Science ®Google Scholar
• Santos D, Coelho T, Alves-Ferreira M, et al. Large normal alleles of ATXN2 decrease age at onset in transthyretin familial amyloid polyneuropathy Val30Met patients. Ann Neurol. 2019;85(2):251–258.
   PubMed Web of Science ®Google Scholar
• Gorram F, Alarcon F, Perdry H, et al. Refine penetrance estimates in the main pathogenic variants of transthyretin hereditary (familial) amyloid polyneuropathy (TTR-FAP) using a new non-parametric approach (NPSE). Amyloid. 2017;24(sup1):115–116.
   PubMed Web of Science ®Google Scholar
• Koike H, Misu K, Ikeda S, et al. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form. Arch Neurol. 2002;59(11):1771–1776.
   PubMedGoogle Scholar
• Kurian SM, Novais M, Whisenant T, et al. Peripheral blood cell gene expression diagnostic for identifying symptomatic transthyretin amyloidosis patients: male and female specific signatures. Theranostics. 2016;6(11):1792–1809.
   PubMed Web of Science ®Google Scholar
• Bonaïti B, Alarcon F, Bonaïti-Pellié C, et al. Parent-of-origin effect in transthyretin related amyloid polyneuropathy. Amyloid. 2009;16(3):149–150.
   PubMed Web of Science ®Google Scholar
• Olsson M, Hellman U, Planté-Bordeneuve V, et al. Mitochondrial haplogroup is associated with the phenotype of familial amyloidosis with polyneuropathy in Swedish and French patients. Clin Genet. 2009;75(2):163–168.
   PubMed Web of Science ®Google Scholar
• Bonaïti B, Olsson M, Hellman U, et al. TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance? Eur J Hum Genet. 2010;18(8):948–952.
   PubMed Web of Science ®Google Scholar
• Santos D, Santos MJ, Alves-Ferreira M, et al. mtDNA copy number associated with age of onset in familial amyloid poly- neuropathy. J Neurol Neurosurg Psychiatry. 2018;89(3):300–304.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Haettner E, Nordenson I, et al. Homozygosity for the transthyretin-met30-gene in two Swedish sibs with familial amyloidotic polyneuropathy. Clin Genet. 1988;34(5):333–338.
   PubMed Web of Science ®Google Scholar
• Tojo K, Sekijima Y, Machida K, et al. Amyloidogenic transthyretin Val30Met homozygote showing unusually early-onset familial amyloid polyneuropathy. Muscle Nerve. 2008;37(6):796–803.
   PubMed Web of Science ®Google Scholar
• Jacob EK, Edwards WD, Zucker M, et al. Homozygous transthyretin mutation in an African American Male. J Mol Diagn. 2007;9(1):127–131.
   PubMed Web of Science ®Google Scholar
• Reddi HV, Jenkins S, Theis J, et al. Homozygosity for the V122I mutation in transthyretin is associated with earlier onset of cardiac amyloidosis in the African American population in the seventh decade of life. J Mol Diagn. 2014;16(1):68–74.
   PubMed Web of Science ®Google Scholar